MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-29-0015643
Antilia Pharma Private Limited
Antilia Pharma Private Limited - trading in Sangli, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.02 Cr
▲ 21% YoY
Net profit · FY 2025
₹4.34 Lakh
Net margin 4.3%
EBITDA · FY 2025
₹9.27 Lakh
EBITDA margin 9.1%
Authorised capital
₹30 Lakh
Registered with MCA
Paid-up capital
₹30 Lakh
Issued & subscribed
Open charges
₹12.5 Lakh
Secured borrowings
Company age
8 yrs
Est. 2018
Employees · EPFO
6
Provident fund records
About Antilia Pharma Private Limited
Data last updated:
Antilia Pharma Private Limited is a private limited company based in Sangli, Maharashtra, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 16 March 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U51909PN2018PTC175428. Its GSTIN is 27AAQCA6532L1Z6 (Maharashtra).
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹30 Lakh. It is led by directors including Vinayak Kiran Patole (Managing Director) and Mohiddin Ismail Mujawar (Whole-Time Director).
Its last annual general meeting (AGM) was held on 25 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S.No. 4887/2/3 Rajnagar Chintamaninagar Sangli., Maharashtra, India – 416416.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.02 Cr, a growth of 21% compared to the previous year. For the same year it recorded a net profit of ₹4.34 Lakh (net margin 4.3%) and EBITDA of ₹9.27 Lakh (EBITDA margin 9.1%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 15% over five years.
The company has about 6 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹12.5 Lakh on record. The company has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in August 2021. Its 10 peer companies in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles) are compared by revenue, 5 larger and 5 smaller; the largest is Arbn Sports India Private Limited with revenue of ₹1.02 Cr.
Antilia Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-29-0015643). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51909PN2018PTC175428
Registration Number 175428
Incorporation Date 16 March 2018
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 25 July 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-29-0015643
Key People
Vinayak Kiran Patole Managing Director Mohiddin Ismail Mujawar Whole-Time Director Shaliwahan Vishwanath Pattanshetti Director Recognitions & Rankings of Antilia Pharma
Contact details
Antilia Pharma Private Limited's registered office is in Sangli, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressS.No. 4887/2/3 Rajnagar Chintamaninagar Sangli., Maharashtra, India – 416416
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Antilia Pharma Private Limited, buy the company report.
Comprehensive company report
Antilia Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Antilia Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Antilia Pharma Private Limited, buy the company report.
Financials of Antilia Pharma Private Limited
FY 2025 filings availableAntilia Pharma Private Limited reported revenue of ₹1.02 Cr (up 21% YoY) for FY 2025.
Revenue · FY 2025
₹1.02 Cr ▲ 21%
Net profit · FY 2025
₹4.34 Lakh margin 4.3%
EBITDA · FY 2025
₹9.27 Lakh margin 9.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 21%
3 years · compounded
▲ 14%
5 years · compounded
▲ 15%
EBITDA CAGR growth
1 year
▲ 137%
3 years · compounded
▲ 77%
5 years · compounded
▲ 41%
Revenue has grown at a compounded annual rate (CAGR) of 15% over five years, including 21% growth in the latest year. EBITDA rose 137% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.27 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.34 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.1% | ||||
| Net Profit Margin | 4.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Antilia Pharma Private Limited, buy the company report.
Board of directors of Antilia Pharma Private Limited
Antilia Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vinayak Kiran Patole Also directs: Antilia Remedies Private Limited | Managing Director | 16 Mar 2018 | 8 Years 7 Months | Current |
| Mohiddin Ismail Mujawar | Whole-Time Director | 16 Mar 2018 | 8 Years 7 Months | Current |
| Shaliwahan Vishwanath Pattanshetti | Director | 30 Jan 2019 | 7 Years 9 Months | Current |
Peer comparison
Antilia Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Arbn Sports India Private Limited | ₹1.02 Cr (FY 2025) | 801.0% | Pune, Maharashtra, India | |||
| Rohan Infocom Private Limited. | ₹1.02 Cr (FY 2024) | 6.0% | New Delhi, Delhi, India | |||
| Heighten Electrical Engineering Private Limited | ₹1.02 Cr (FY 2025) | 84.0% | Vijayawada, Andhra Pradesh, India | |||
| Ekas Books Private Limited | ₹1.02 Cr (FY 2025) | 60.0% | New Delhi, Delhi, India | |||
| Keller & Kalmbach India Private Limited | ₹1.02 Cr (FY 2025) | 34.0% | New Delhi, Delhi, India | |||
| Antilia Pharma Private Limitedthis company | ₹1.02 Cr (FY 2025) | ₹4.34 Lakh | 4.3% | 21.0% | 6 | Sangli, Maharashtra, India |
| Btobig Impex Private Limited | ₹1.02 Cr (FY 2025) | -59.0% | Mumbai, Maharashtra, India | |||
| Hale N Healthy Medicare Private Limited | ₹1.02 Cr (FY 2025) | -64.0% | Kachna, Chhattisgarh, India | |||
| Alae Super Jee Martyy Private Limited | ₹1.02 Cr (FY 2025) | 3.0% | Barabanki, Uttar Pradesh, India | |||
| Devat Ram & Company Private Limited | ₹1.01 Cr (FY 2025) | -93.0% | Kolkata, West Bengal, India | |||
| Technoland Systems Limited | ₹1.01 Cr (FY 2024) | 7.0% | New Delhi, Delhi, India |
To see the full peer comparison of Antilia Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹12.5 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 May 2024 | 100937838 | Others | ₹12.5 Lakh | Open |
Total charge records: 1 View all charges
Deals & funding
Antilia Pharma Private Limited has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in August 2021.
Total deals
3
Rights issues
2
Secondary share transfer
1
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2021 | Rights issue | ₹2 Lakh | Investors: 4 individuals |
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 4 individuals |
| May 2018 | Rights issue | ₹22 Lakh | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Antilia Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Antilia Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Antilia Pharma Private Limited has a workforce of 6 employees on its EPFO records as of Mar 21, 2024, across 1 active EPFO establishment.
Employee count
6
Active EPFO establishments
1
GST
Antilia Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAQCA6532L1Z6 | Maharashtra | Active | 19 Apr 2018 |
To see the full GST registrations and return filing status of Antilia Pharma Private Limited, buy the company report.
Recent activity
Antilia Pharma Private Limited has 5 board changes on record since 2018: 4 appointments and 1 cessation. The latest: Yogesh Namdev Jadhav ceased to be Whole-Time Director on 07 Oct 2024.
AGM
Antilia Pharma Private Limited last Annual general meeting of members was held on 25 Jul 2025 as per latest MCA records.
Filing
Antilia Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Ceased
Yogesh Namdev Jadhav ceased to be Whole-Time Director.
Charges
A charge with Others amounted to Rs. 12.50 Lakh with Charge ID 100937838 was registered on 30 May 2024.
Appointed
Shaliwahan Vishwanath Pattanshetti was appointed as Director.
Appointed
Mohiddin Ismail Mujawar was appointed as Whole-Time Director.
Appointed
Vinayak Kiran Patole was appointed as Managing Director.
Appointed
Yogesh Namdev Jadhav was appointed as Whole-Time Director.
Incorporation
16 Mar 2018
Antilia Pharma Private Limited was registered on 16 Mar 2018 with Roc Pune & aged 8 years 7 months as per MCA records.
Frequently asked questions
Antilia Pharma is an active private limited company based in Sangli, Maharashtra, India. The company works in specialty, within the trading industry. It was incorporated on 16 March 2018 (8+ years old) and is registered under CIN U51909PN2018PTC175428.
Antilia Pharma has 3 current directors:
- Vinayak Kiran Patole - Managing Director
- Mohiddin Ismail Mujawar - Whole-Time Director
- Shaliwahan Vishwanath Pattanshetti - Director
The latest financial statements of Antilia Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 25 July 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Antilia Pharma is 27AAQCA6532L1Z6, registered in Maharashtra.
The CIN (Corporate Identification Number) of Antilia Pharma is U51909PN2018PTC175428. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Antilia Pharma was incorporated on 16 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Pune.
Antilia Pharma has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in August 2021.
The peers of Antilia Pharma by revenue are Arbn Sports India Private Limited, Rohan Infocom Private Limited, Heighten Electrical Engineering Private Limited, Ekas Books Private Limited, Keller & Kalmbach India Private Limited and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Yogesh Namdev Jadhav ceased to be Whole-Time Director on 07 Oct 2024. Shaliwahan Vishwanath Pattanshetti was appointed as Director on 30 Jan 2019. Mohiddin Ismail Mujawar was appointed as Whole-Time Director on 16 Mar 2018. Antilia Pharma has 5 board changes on record in total.
Yes, Antilia Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-29-0015643).
The registered office of Antilia Pharma is at S.No. 488723 Rajnagar Chintamaninagar Sangli., Maharashtra, India – 416416.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages